Source: Cancer Chemotherapy and Pharmacology. Unidade: FMRP
Subjects: MOTILIDADE GASTROINSTESTINAL, ESVAZIAMENTO GÁSTRICO, MÚSCULO LISO
ABNT
SOARES, Pedro M. G. et al. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemotherapy and Pharmacology, v. 63, n. 1, p. 91-98, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00280-008-0715-9. Acesso em: 18 nov. 2024.APA
Soares, P. M. G., Mota, J. M. S. C., Gomes, A. S., Oliveira, R. B. de, Assreuy, A. M. S., Brito, G. A. C., et al. (2008). Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemotherapy and Pharmacology, 63( 1), 91-98. doi:10.1007/s00280-008-0715-9NLM
Soares PMG, Mota JMSC, Gomes AS, Oliveira RB de, Assreuy AMS, Brito GAC, Santos AA, Ribeiro R de A, Souza MHLP de. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution [Internet]. Cancer Chemotherapy and Pharmacology. 2008 ; 63( 1): 91-98.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00280-008-0715-9Vancouver
Soares PMG, Mota JMSC, Gomes AS, Oliveira RB de, Assreuy AMS, Brito GAC, Santos AA, Ribeiro R de A, Souza MHLP de. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution [Internet]. Cancer Chemotherapy and Pharmacology. 2008 ; 63( 1): 91-98.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00280-008-0715-9